In early pilot studies raised concentrations of BNP (with a sensitivity of 97% and a specificity of 84% (9)) distinguished heart failure from other causes of dyspnoea more accurately than left-ventricular ejection fraction, atrial natriuretic peptide (ANP) and N-terminal ANP did. Here, NPPB is linked to heart failure.